A pooled analysis revealed that association between obesity and metabolic syndrome is more frequently observed in TNBC vs. ER+/HER2 tumors, particularly in younger women (age < 50) [29]. The gene discussed is ERBB2; the disease is obesity due to melanocortin 4 receptor deficiency.